AU2008212752A1 - Novel nucleoside analogs for treatment of viral infections - Google Patents

Novel nucleoside analogs for treatment of viral infections Download PDF

Info

Publication number
AU2008212752A1
AU2008212752A1 AU2008212752A AU2008212752A AU2008212752A1 AU 2008212752 A1 AU2008212752 A1 AU 2008212752A1 AU 2008212752 A AU2008212752 A AU 2008212752A AU 2008212752 A AU2008212752 A AU 2008212752A AU 2008212752 A1 AU2008212752 A1 AU 2008212752A1
Authority
AU
Australia
Prior art keywords
virus
compound
ethynyl
alkynyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2008212752A
Other languages
English (en)
Inventor
Yen Liang Chen
Jeyaraj Duraiswamy
Zheng Yin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39462074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2008212752(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2008212752A1 publication Critical patent/AU2008212752A1/en
Priority to AU2012204097A priority Critical patent/AU2012204097B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2008212752A 2007-02-09 2008-02-07 Novel nucleoside analogs for treatment of viral infections Abandoned AU2008212752A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2012204097A AU2012204097B2 (en) 2007-02-09 2012-07-11 Novel nucleoside analogs for treatment of viral infections

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP07102027 2007-02-09
EP07102027.5 2007-02-09
EP08150003.5 2008-01-02
EP08150003 2008-01-02
PCT/EP2008/051527 WO2008095993A1 (en) 2007-02-09 2008-02-07 Novel nucleoside analogs for treatment of viral infections

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2012204097A Division AU2012204097B2 (en) 2007-02-09 2012-07-11 Novel nucleoside analogs for treatment of viral infections

Publications (1)

Publication Number Publication Date
AU2008212752A1 true AU2008212752A1 (en) 2008-08-14

Family

ID=39462074

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008212752A Abandoned AU2008212752A1 (en) 2007-02-09 2008-02-07 Novel nucleoside analogs for treatment of viral infections

Country Status (18)

Country Link
US (1) US8278282B2 (cg-RX-API-DMAC7.html)
EP (1) EP2132216B1 (cg-RX-API-DMAC7.html)
JP (1) JP2010518047A (cg-RX-API-DMAC7.html)
KR (1) KR20090109102A (cg-RX-API-DMAC7.html)
CN (1) CN101600726B (cg-RX-API-DMAC7.html)
AR (1) AR065249A1 (cg-RX-API-DMAC7.html)
AT (1) ATE533774T1 (cg-RX-API-DMAC7.html)
AU (1) AU2008212752A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0807222A2 (cg-RX-API-DMAC7.html)
CA (1) CA2675462A1 (cg-RX-API-DMAC7.html)
CL (1) CL2008000409A1 (cg-RX-API-DMAC7.html)
EA (1) EA200901080A1 (cg-RX-API-DMAC7.html)
ES (1) ES2381093T3 (cg-RX-API-DMAC7.html)
MX (1) MX2009008495A (cg-RX-API-DMAC7.html)
PE (1) PE20090070A1 (cg-RX-API-DMAC7.html)
PT (1) PT2132216E (cg-RX-API-DMAC7.html)
TW (1) TW200838550A (cg-RX-API-DMAC7.html)
WO (1) WO2008095993A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010015643A1 (en) * 2008-08-06 2010-02-11 Novartis Ag New antiviral modified nucleosides
CN102526087B (zh) * 2010-12-30 2014-09-03 南开大学 核苷类化合物在制备治疗肠病毒71(ev71)感染疾病药物的应用
CN105669783B (zh) * 2014-12-03 2019-11-12 广东东阳光药业有限公司 一种制备呋喃糖的方法
JP2018523665A (ja) 2015-08-06 2018-08-23 キメリックス インコーポレイテッド 抗ウイルス剤として有用なピロロピリミジンヌクレオシドおよびその類縁体
RU2720811C2 (ru) 2015-09-23 2020-05-13 Мерк Шарп И Доум Лимитед 4'-замещенные нуклеозидные ингибиторы обратной транскриптазы и их получение
EA201892448A1 (ru) * 2016-04-28 2019-06-28 Эмори Юниверсити Алкинсодержащие нуклеотидные и нуклеозидные терапевтические композиции и связанные с ними способы применения
TW201815821A (zh) * 2016-07-18 2018-05-01 美商再生元醫藥公司 抗茲卡病毒抗體及使用方法
TW201811339A (zh) * 2016-08-12 2018-04-01 美商艾洛斯生物製藥公司 經取代之核苷、核苷酸及其類似物
EP3684771B1 (en) 2017-09-21 2024-11-27 Chimerix, Inc. Morphic forms of 4-amino-7-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-methyl-7h-pyrrolo(2,3-d)pyrimidine-5-carboxamide and uses thereof
US11718534B2 (en) 2019-04-23 2023-08-08 Elementis Specialties, Inc. Slurry compositions containing mixed branched alkyl organoclay compositions
US20250057849A1 (en) * 2021-12-22 2025-02-20 Cj Cheiljedang Corporation Antiviral composition comprising nucleoside analogues derived from nucleic acid and pharmaceutically acceptable salt thereof
CN117430571B (zh) * 2022-07-15 2025-08-29 宜昌东阳光长江药业股份有限公司 一种制备吡喃葡萄糖基衍生物的关键中间体及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0206614A (pt) * 2001-01-22 2004-02-17 Merck & Co Inc Composto, composição farmacêutica, método para inibir a polimerase viral de rna dependente de rna e/ou inibir a replicação viral de rna dependente de rna, método para tratar uma infecção viral de rna dependente de rna, e, uso de um composto
JP2005511764A (ja) * 2001-12-14 2005-04-28 アルコン，インコーポレイテッド 緑内障の処置のためのアミノアルキルベンゾフラン−５−オール化合物
JP2005527499A (ja) * 2002-02-13 2005-09-15 メルク　エンド　カムパニー　インコーポレーテッド ヌクレオシド化合物を用いてオルトポックスウイルスの複製を阻害する方法
MXPA04010983A (es) * 2002-05-06 2005-02-14 Genelabs Tech Inc Derivados de nucleosidos para tratar infecciones por el virus de la hepatitis c.
TW200418498A (en) * 2002-09-30 2004-10-01 Genelabs Tech Inc Nucleoside derivatives for treating hepatitis C virus infection
US20040259934A1 (en) * 2003-05-01 2004-12-23 Olsen David B. Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
WO2005042556A1 (en) * 2003-10-27 2005-05-12 Genelabs Technologies, Inc. Nucleoside compounds for treating viral infections

Also Published As

Publication number Publication date
CA2675462A1 (en) 2008-08-14
CL2008000409A1 (es) 2008-08-29
ES2381093T3 (es) 2012-05-23
PE20090070A1 (es) 2009-03-19
WO2008095993A1 (en) 2008-08-14
BRPI0807222A2 (pt) 2014-04-29
JP2010518047A (ja) 2010-05-27
ATE533774T1 (de) 2011-12-15
US20100227833A1 (en) 2010-09-09
CN101600726A (zh) 2009-12-09
EP2132216A1 (en) 2009-12-16
EP2132216B1 (en) 2011-11-16
AR065249A1 (es) 2009-05-27
MX2009008495A (es) 2009-08-20
PT2132216E (pt) 2012-02-20
KR20090109102A (ko) 2009-10-19
US8278282B2 (en) 2012-10-02
TW200838550A (en) 2008-10-01
CN101600726B (zh) 2013-03-27
EA200901080A1 (ru) 2010-02-26

Similar Documents

Publication Publication Date Title
EP2132216B1 (en) Novel nucleoside analogs for treatment of viral infections
US20100144655A1 (en) Organic compounds
WO2010015637A1 (en) New antiviral modified nucleosides
CA2490200C (en) 2' and 3'-nucleoside prodrugs for treating flaviviridae infections
CN104163841B (zh) 用于治疗黄病毒感染的修饰的2’和3’-核苷前药
EP1658302B1 (en) Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis c
KR101396696B1 (ko) 스피로피롤리딘, 및 ｈｃｖ 및 ｈｉｖ 감염에 대한 그의 용도
CA2527657C (en) Modified fluorinated nucleoside analogues
EP1898934A1 (en) Nucleosides with non-natural bases as anti-viral agents
KR20070073805A (ko) 플라비바이러스, 페스티바이러스 및 헤파시바이러스를치료하기 위한 방법 및 조성물
US20160289259A1 (en) 2'-Branched Nucleosides for Treatment of Viral Infections
AU2012204097B2 (en) Novel nucleoside analogs for treatment of viral infections
HK1189235A (en) Modified 2' and 3' -nucleoside prodrugs for treating flaviviridae infections
HK1189234A (en) Modified 2' and 3'-nucleoside prodrugs for treating flaviridae infections
HK1187349B (en) Modified fluorinated nucleoside analogues

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted